Literature DB >> 26617353

The Handicap of Hidradenitis Suppurativa.

Inge Elizabeth Deckers1, Alexa Boer Kimball2.   

Abstract

Hidradenitis suppurativa (HS) is a chronic skin disease, with painful, foul-smelling, recurring inflammation, leading to a diminished quality of life. Patients with HS also often suffer from depression, have an impaired sexual health, and may have difficulty performing their work duties.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acne inversa; Depression; Dermatology life quality index; Morbidity; Psychological impact; Quality of life; Social impact; Work

Mesh：

Year:  2015        PMID： 26617353     DOI： 10.1016/j.det.2015.07.003

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  16 in total

1.  The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.

Authors:  Nicolas Kluger; Martta Ranta; Martina Serlachius
Journal:  Skin Appendage Disord       Date:  2017-01-12

2.  Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.

Authors:  Peter Theut Riis; Ditte Marie Saunte; Viktoria Sigsgaard; Axel Patrice Villani; Philippe Guillem; José C Pascual; Naomi N Kappe; Annika M J D Vanlaerhoven; Hessel H van der Zee; Errol P Prens; Moetaz El-Domyati; Hossam Abdel-Wahab; Nayera Moftah; Rania Abdelghani; Eugenia Agut-Busquet; Jorge Romaní; Carol Hlela; Lerinza van den Worm; Vincenzo Bettoli; Giada Calamo; Mehmet Ali Gürer; Burcu Beksaç; Lukasz Matusiak; Amelia Glowaczewska; Jacek C Szepietowski; Lennart Emtestam; Jan Lapins; Hassan Riad Kottb; Mohammad Fatani; Lisa Weibel; Martin Theiler; Maïa Delage-Toriel; Thi Thanh Hong Lam; Aude Nassif; Pierre-Andre Becherel; Mateja Dolenc-Voljc; Nejib Doss; Dorra Bouazzi; Farida Benhadou; Veronique Del Marmol; Gregor B E Jemec
Journal:  Arch Dermatol Res       Date:  2020-03-12       Impact factor: 3.017

3.  The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.

Authors:  J S Kirby; L Thorlacius; B Villumsen; J R Ingram; A Garg; K B Christensen; M Butt; S Esmann; J Tan; G B E Jemec
Journal:  Br J Dermatol       Date:  2019-12-26       Impact factor: 9.302

Review 4.  Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].

Authors:  Zarine S Patel; Lauren K Hoffman; Dawn C Buse; Amy S Grinberg; Ladan Afifi; Steven R Cohen; Michelle A Lowes; Elizabeth K Seng
Journal:  Curr Pain Headache Rep       Date:  2017-11-01

5.  The health-related quality of life in hyperhidrosis and co-morbidities.

Authors:  Ole B Pedersen; Gregor B E Jemec; Mattias A S Henning; Kristina S Ibler; Isabella Loft; Sisse R Ostrowski; Christian Erikstrup; Kaspar R Nielsen; Mie T Bruun; Henrik Ullum; Maria Didriksen; Khoa M Dinh
Journal:  Qual Life Res       Date:  2022-02-22       Impact factor: 4.147

Review 6.  Treatment of Hyperhidrosis: An Update.

Authors:  Mattias A S Henning; Dorra Bouazzi; Gregor B E Jemec
Journal:  Am J Clin Dermatol       Date:  2022-07-01       Impact factor: 6.233

7.  Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.

Authors:  Linnea Thorlacius; Solveig Esmann; Iben Miller; Gabrielle Vinding; Gregor B E Jemec
Journal:  Skin Appendage Disord       Date:  2019-02-14

8.  Disfiguring Hidradenitis Suppurativa of the Face.

Authors:  Gianmarco Capasso; Gabriella Fabbrocini; Claudio Marasca
Journal:  Skin Appendage Disord       Date:  2021-08-26

9.  A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.

Authors:  L Thorlacius; J R Ingram; B Villumsen; S Esmann; J S Kirby; A B Gottlieb; J F Merola; R Dellavalle; S M Nielsen; R Christensen; A Garg; G B E Jemec
Journal:  Br J Dermatol       Date:  2018-07-05       Impact factor: 11.113

10.  Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.

Authors:  Kristina Navrazhina; John W Frew; Patricia Gilleaudeau; Mary Sullivan-Whalen; Sandra Garcet; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2021-02-03       Impact factor: 14.290
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.